TEM Company Profile and Key Details

NASDAQ : TEM

Tempus AI

$48.83

-0.31-0.63%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Tempus AI, Inc. (TEM) stock declined over -0.63%, trading at $48.83 on NASDAQ, down from the previous close of $49.14. The stock opened at $48.46, fluctuating between $47.69 and $49.37 in the recent session.

Stock Snapshot

49.14

Prev. Close

8.48B

Market Cap

47.69

Day Low

-34.63

P/E Ratio

-1.41

EPS (TTM)

N/A

Cash Flow per Share

48.46

Open

173.73M

Number of Shares

49.37

Day High

61.91%

Free Float in %

N/A

Book Value

2.58M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 24, 2026	48.46	49.37	47.69	48.83	2.63M
Mar 23, 2026	47.90	49.98	47.60	49.14	4.77M
Mar 20, 2026	48.40	49.33	46.13	46.96	4.48M
Mar 19, 2026	47.38	49.46	46.76	48.74	4.18M
Mar 18, 2026	50.15	50.58	48.64	48.69	4.6M
Mar 17, 2026	50.93	51.98	50.53	50.84	3.03M
Mar 16, 2026	51.44	52.67	49.81	50.88	4.95M
Mar 13, 2026	50.16	51.45	49.56	49.98	4.99M
Mar 12, 2026	51.84	51.84	49.32	49.53	6.01M
Mar 11, 2026	51.54	53.63	51.38	52.68	4.06M
Mar 10, 2026	52.38	53.05	50.73	50.90	4.28M
Mar 09, 2026	50.89	52.77	49.83	52.32	4.6M
Mar 06, 2026	51.86	53.50	51.57	52.26	3.42M
Mar 03, 2026	51.13	52.87	48.75	51.40	6.93M
Mar 02, 2026	50.95	53.35	50.62	53.31	5.66M
Feb 27, 2026	54.23	54.54	52.16	53.25	4.52M
Feb 26, 2026	53.19	55.46	51.69	55.41	7.52M
Feb 25, 2026	57.08	57.74	53.05	53.71	10.53M
Feb 24, 2026	56.56	58.76	56.29	57.95	5.16M
Feb 23, 2026	57.53	58.33	55.85	57.29	4.03M

Contact Details

Chicago, IL 60654

United States

https://www.tempus.com 800 976 5448

About Company

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Stock Peers

BTSGU

3.835+2.72%

BrightSpring Health Services, Inc. Tangible Equity Unit$144.79 NUTX

4.51+4.75%

Nutex Health, Inc.$99.49 HQY

0.46+0.56%

HealthEquity, Inc.$82.10 GEHC

-0.69-0.96%

GE HealthCare Technologies Inc.$70.96 WGS

-3.47-4.81%

GeneDx Holdings Corp.$68.67 BTSG

1.21+2.87%

BrightSpring Health Services, Inc. Common Stock$43.31 OMCL

0.15+0.44%

Omnicell, Inc.$34.46 PINC

0.09+0.32%

Premier, Inc.$28.26 HTFL

1.15+4.29%

Heartflow, Inc. Common Stock$27.97 CCLDO

CareCloud, Inc.$26.18

Company Overview

Tempus AI, Inc. (NASDAQ:TEM) closed at $48.83 USD, losing -$0.31 (-0.63%) from the previous close of $49.14. The stock is currently mid-range between its 52-week high and low $36.22 and $104.32. With a market capitalization of about $8.48 billion, Tempus AI, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~5.31). Key stats such as the average daily volume over the past year has been around 5.39 million shares, volume is running light vs its 52-week average. Headquartered in Chicago, IL, Tempus AI, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Eric Lefkofsky, the company employs approximately 2,400 people and listed since June 14, 2024. Tempus AI, Inc. operates as a healthcare technology company.

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 -1.01%, SMA50 -10.54%, SMA200 -20.92%). The stock’s 14-day RSI is 44.36 (neutral), while the ATR of 3.7 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -46.88% below its high and over 52.98% above its low. Average 10-day trading volume of 4.09 million shares is below the 3-month average of 5.27 million, indicating normal recent market interest.

Valuation Metrics

Tempus AI, Inc. trades at a P/E ratio of -35.08, slightly below the S&P 500 average, with a price-to-sales ratio of 6.74 and a price-to-book ratio of 17.5 reflecting a rich premium to book value. The P/FCF stands at -21.21, also below market averages. Compared to sector medians, Tempus AI, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Dividend & Fair Value

Tempus AI, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$37.02. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Tempus AI, Inc. generated EPS of -$1.41 over the past year. Five-year average earnings growth is 1.21%. Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 19 Buy ratings, 5 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $110.00 to $59.00. The high target offers 125.27% upside. The low target suggests 20.83% downside. The mean target is $87.70. This offers 79.6% upside. Tempus AI, Inc. earnings surprise history is a mixed track record. The quarter that ended November 04, 2025, missed forecasts by -31.25%. The prior quarter beat by -4.3%. Over the last six quarters, Apple has recorded several small beats. These include 6.78% in August 06, 2024.

Shareholding & Insider Activity

Tempus AI, Inc. has 168.68 million shares outstanding. The public float is 102.03 million shares, elevated short interest at 20.24% of float. This equals 25.97 million shares. The short ratio is 2.46 days. Institutional investors hold 86.51% of the float. Insiders own 39.9%. LEFKOFSKY ERIC P holds 1.99 million shares, Fukushima Ryan has 694.35 thousand shares and Rogers James William has 127.25 thousand shares. Over the past six months, insider transactions show net selling. They sold 173.26 thousand shares across 36 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Tempus AI has not generated any revenue.
On valuation metrics, Tempus AI trades at a P/E of -35.08, P/S of 6.74 and P/B of 17.50. The current ratio is 3.13 and quick ratio is 3.00. Operationally, the company’s inventory turnover is 7.46 and cash conversion cycle is 60.69 days. Debt-to-equity is 1.66, supported by a cash flow-to-debt ratio of -0.49.

Price Forecast & Outlook

Our AI price prediction model suggests that Tempus AI, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -5.32%, with price expected at $46.23 by April 06, 2026, within a range of $43.21 to $49.34 3-Month Outlook: Projected rise of 4.38%, reaching $50.97 by June 19, 2026, with a range of $47.74 to $53.44. 1-Year Outlook: Projected gain of 30.66%, with price at $63.80 by March 23, 2027, within a range of $59.17 to $68.90.

Key Takeaways

Tempus AI, Inc. (NASDAQ:TEM) shares are up 13.09% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Tempus AI, Inc. trading at a premium to the broader market with a P/E of -35.08. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $79.49, suggesting 62.79% upside. Our AI forecast model points to short-term weakness (-5.32% over two weeks), a medium-term rise (4.38% over three months), and a longer-term gain (30.66% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Tempus AI, Inc. (TEM) stock price?

Tempus AI, Inc. (NASDAQ: TEM) stock price is $48.83 in the last trading session. During the trading session, TEM stock reached the peak price of $49.37 while $47.69 was the lowest point it dropped to. The percentage change in TEM stock occurred in the recent session was -0.63% while the dollar amount for the price change in TEM stock was - $0.31.

TEM's industry and sector of operation?

The NASDAQ listed TEM is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Tempus AI, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TEM?

No Data

How TEM did perform over past 52-week?

TEM's closing price is 34.81% higher than its 52-week low of $36.22 where as its distance from 52-week high of $104.32 is -53.19%.

How many employees does TEM have?

Number of TEM employees currently stands at 2,400.

Link for TEM official website?

Official Website of TEM is: https://www.tempus.com

How do I contact TEM?

TEM could be contacted at phone 800 976 5448 and can also be accessed through its website. TEM operates from 600 West Chicago Avenue, Chicago, IL 60654, United States.

How many shares of TEM are traded daily?

TEM stock volume for the day was 2.58M shares. The average number of TEM shares traded daily for last 3 months was 5.39M.

What is the market cap of TEM currently?

The market value of TEM currently stands at $8.48B with its latest stock price at $48.83 and 173.73M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	2400
Beta	5.31
Sales or Revenue	N/A
5Y Sales Change%	7.614%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Medical - Healthcare Information Services

TEM Company Profile and Key Details

Tempus AI

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook